<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD006230.pub2" GROUP_ID="LIVER" ID="748706011815283979" MERGED_FROM="" MODIFIED="2008-11-12 12:10:53 +0100" MODIFIED_BY="dimitrinka nikolova" NOTES="&lt;p&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;Exported from Review Manager 4.2.8&lt;br&gt;Exported from Review Manager 4.3 Beta&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2008-11-12 12:10:53 +0100" NOTES_MODIFIED_BY="dimitrinka nikolova" REVIEW_NO="09" REVMAN_SUB_VERSION="5.0.16" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="3.5">
<COVER_SHEET MODIFIED="2008-11-12 12:10:53 +0100" MODIFIED_BY="dimitrinka nikolova">
<TITLE MODIFIED="2008-10-17 15:43:44 +0100" MODIFIED_BY="Dimitrinka Nikolova">Cholecystectomy for patients with silent gallstones</TITLE>
<CONTACT>
<PERSON ID="EDD1B9F582E26AA20135ECF1AB0B3200" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Kurinchi Selvan</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Gurusamy</LAST_NAME>
<SUFFIX>MBBS MS MRCS</SUFFIX>
<POSITION>Research Fellow</POSITION>
<EMAIL_1>kurinchi2k@hotmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE>+44 (0)7944 629303</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>University Department of Surgery</DEPARTMENT>
<ORGANISATION>Royal Free Hospital and University College School of Medicine</ORGANISATION>
<ADDRESS_1>9th Floor, Royal Free Hospital</ADDRESS_1>
<ADDRESS_2>Pond Street</ADDRESS_2>
<CITY>London</CITY>
<ZIP>NW3 2QG</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 207 830 2757</PHONE_1>
<PHONE_2/>
<FAX_1>+44 207 830 2688</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CONTACT>
<CREATORS MODIFIED="2008-11-12 12:07:10 +0100" MODIFIED_BY="Dimitrinka Nikolova">
<PERSON ID="EDD1B9F582E26AA20135ECF1AB0B3200" ROLE="AUTHOR">
<PREFIX>Dr</PREFIX>
<FIRST_NAME>Kurinchi Selvan</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Gurusamy</LAST_NAME>
<SUFFIX>MBBS MS MRCS</SUFFIX>
<POSITION>Research Fellow</POSITION>
<EMAIL_1>kurinchi2k@hotmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE>+44 (0)7944 629303</MOBILE_PHONE>
<ADDRESS>
<DEPARTMENT>University Department of Surgery</DEPARTMENT>
<ORGANISATION>Royal Free Hospital and University College School of Medicine</ORGANISATION>
<ADDRESS_1>9th Floor, Royal Free Hospital</ADDRESS_1>
<ADDRESS_2>Pond Street</ADDRESS_2>
<CITY>London</CITY>
<ZIP>NW3 2QG</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 207 830 2757</PHONE_1>
<PHONE_2/>
<FAX_1>+44 207 830 2688</FAX_1>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
<PERSON ID="7CEADD7A82E26AA20029B854A6C78ABD" ROLE="AUTHOR">
<PREFIX>Mr</PREFIX>
<FIRST_NAME>Kumarakrishnan</FIRST_NAME>
<MIDDLE_INITIALS/>
<LAST_NAME>Samraj</LAST_NAME>
<SUFFIX/>
<POSITION>Specialist Registrar</POSITION>
<EMAIL_1>kumarsamraj@hotmail.com</EMAIL_1>
<EMAIL_2/>
<URL/>
<MOBILE_PHONE/>
<ADDRESS>
<DEPARTMENT>Department of General Surgery</DEPARTMENT>
<ORGANISATION>John Radcliffe Hospital</ORGANISATION>
<ADDRESS_1/>
<ADDRESS_2/>
<CITY>Oxford</CITY>
<ZIP>OX3 9DU</ZIP>
<REGION/>
<COUNTRY CODE="GB">UK</COUNTRY>
<PHONE_1>+44 1865 741166</PHONE_1>
<PHONE_2/>
<FAX_1/>
<FAX_2/>
</ADDRESS>
<FOOTNOTE/>
</PERSON>
</CREATORS>
<DATES MODIFIED="2008-06-24 15:24:49 +0100" MODIFIED_BY="Dimitrinka Nikolova" NOTES="&lt;p&gt;Minor update: 10/11/06&lt;/p&gt;&lt;p&gt;New studies sought but none found: 12/03/06&lt;/p&gt;&lt;p&gt;Conclusions changed: 06/09/06&lt;/p&gt;" NOTES_MODIFIED="2008-06-24 15:24:49 +0100" NOTES_MODIFIED_BY="Dimitrinka Nikolova">
<UP_TO_DATE>
<DATE DAY="19" MONTH="5" YEAR="2008"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="19" MONTH="5" YEAR="2008"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="6" MONTH="12" YEAR="2009"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2006"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="2007"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2007"/>
</DATES>
<WHATS_NEW MODIFIED="2008-11-12 12:10:53 +0100" MODIFIED_BY="dimitrinka nikolova">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-11-12 12:10:53 +0100" MODIFIED_BY="dimitrinka nikolova">
<DATE DAY="9" MONTH="9" YEAR="2008"/>
<DESCRIPTION>
<P>New searches performed May 2008. Still no studies available. Components for bias assessment updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2008-09-09 13:40:44 +0100" MODIFIED_BY="Sarah Louise Klingenberg">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2008-09-09 13:39:19 +0100" MODIFIED_BY="Sarah Louise Klingenberg">
<DATE DAY="26" MONTH="5" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2008-09-04 16:01:24 +0100" MODIFIED_BY="dimitrinka nikolova">
<INTERNAL_SOURCES MODIFIED="2008-09-04 16:01:24 +0100" MODIFIED_BY="dimitrinka nikolova">
<SOURCE MODIFIED="2008-09-04 16:01:24 +0100" MODIFIED_BY="dimitrinka nikolova">
<NAME>none</NAME>
<COUNTRY CODE="NONE">Not specified</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2008-06-29 06:49:30 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<SOURCE MODIFIED="2008-06-29 06:49:30 +0100" MODIFIED_BY="Kurinchi S Gurusamy">
<NAME>none</NAME>
<COUNTRY CODE="NONE">Not specified</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2008-10-17 16:22:56 +0100" MODIFIED_BY="dimitrinka nikolova">
<SUMMARY>
<TITLE>No evidence to assess surgical treatment in asymptomatic gallstones</TITLE>
<SUMMARY_BODY>
<P>Cholecystectomy is currently advised only for symptomatic gallstones. However, about 4% of patients with asymptomatic gallstones develop symptoms including cholecystitis, obstructive jaundice, pancreatitis, and gallbladder cancer. Literature search was performed for evidence from randomised clinical trials to find whether cholecystectomy was indicated in patients with silent (asymptomatic) gallstones. There is no randomised trial comparing cholecystectomy versus no cholecystectomy in silent gallstones. Further evaluation of observational studies, which measure outcomes such as obstructive jaundice, gallstone-associated pancreatitis, and/or gall-bladder cancer for sufficient duration of follow-up is necessary before randomised trials are designed in order to evaluate whether cholecystectomy or no cholecystectomy is better for asymptomatic gallstones. </P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2008-09-09 13:17:03 +0100" MODIFIED_BY="Sarah Louise Klingenberg">
<ABS_BACKGROUND>
<P>Cholecystectomy is currently advised only for patients with symptomatic gallstones. However, about 4% of patients with asymptomatic gallstones develop symptoms including cholecystitis, obstructive jaundice, pancreatitis, and gallbladder cancer.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To assess the benefits and harms of surgical removal of the gallbladder for patients with asymptomatic gallstones.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2008-09-09 13:17:03 +0100" MODIFIED_BY="Sarah Louise Klingenberg">
<P>We searched <I>The Cochrane Hepato-Biliary Group Controlled Trials Register</I>, the <I>Cochrane Central Register of Controlled Trials</I> (<I>CENTRAL</I>) in <I>The Cochrane Library</I>, <I>MEDLINE</I>, <I>EMBASE,</I> and <I>Science Citation Index Expanded </I>until May 2008.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Only randomised clinical trials (irrespective of language, blinding, or publication status) comparing cholecystectomy and no cholecystectomy were considered for the review. </P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>We were unable to identify any randomised clinical trials comparing cholecystectomy versus no cholecystectomy.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>We were unable to identify any randomised clinical trial comparing cholecystectomy versus no cholecystectomy.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>There are no randomised trials comparing cholecystectomy versus no cholecystectomy in patients with silent gallstones. Further evaluation of observational studies, which measure outcomes such as obstructive jaundice, gallstone-associated pancreatitis, and/or gall-bladder cancer for sufficient duration of follow-up is necessary before randomised trials are designed in order to evaluate whether cholecystectomy or no cholecystectomy is better for asymptomatic gallstones.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2008-10-17 15:52:41 +0100" MODIFIED_BY="dimitrinka nikolova">
<BACKGROUND MODIFIED="2008-09-04 16:04:09 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>About 10% to 15% of the adult western population have gallstones (<LINK REF="REF-NIH-1992" TYPE="REFERENCE">NIH 1992</LINK>; <LINK REF="REF-Halldestam-2004" TYPE="REFERENCE">Halldestam 2004</LINK>). The annual incidence of gallstones is about 1 in 200 people (<LINK REF="REF-NIH-1992" TYPE="REFERENCE">NIH 1992</LINK>). Only 1% to 4% of people with gallstones become symptomatic in a year (<LINK REF="REF-NIH-1992" TYPE="REFERENCE">NIH 1992</LINK>; <LINK REF="REF-Halldestam-2004" TYPE="REFERENCE">Halldestam 2004</LINK>). The reported incidence of common bile duct stones at the time of cholecystectomy varies between 5% (<LINK REF="REF-Kama-2001" TYPE="REFERENCE">Kama 2001</LINK>; <LINK REF="REF-Hemli-2004" TYPE="REFERENCE">Hemli 2004</LINK>) and 11% (<LINK REF="REF-Pitluk-1979" TYPE="REFERENCE">Pitluk 1979</LINK>; <LINK REF="REF-Duensing-2000" TYPE="REFERENCE">Duensing 2000</LINK>; <LINK REF="REF-Rojas_x002d_Ortega-2003" TYPE="REFERENCE">Rojas-Ortega 2003</LINK>). Laparoscopic cholecystectomy is currently preferred over open cholecystectomy for elective cholecystectomy (<LINK REF="REF-NIH-1992" TYPE="REFERENCE">NIH 1992</LINK>; <LINK REF="REF-Fullarton-1994" TYPE="REFERENCE">Fullarton 1994</LINK>; <LINK REF="REF-Livingston-2004" TYPE="REFERENCE">Livingston 2004</LINK>; <LINK REF="REF-Keus-2006" TYPE="REFERENCE">Keus 2006</LINK>) and is advised only for symptomatic gallstones (<LINK REF="REF-NIH-1992" TYPE="REFERENCE">NIH 1992</LINK>).</P>
<P>Porcelain gallbladder (ie, calcified gallbladder) has been reported to be associated with a 7% risk of gallbladder cancer (<LINK REF="REF-Stephen-2001" TYPE="REFERENCE">Stephen 2001</LINK>). Although the association between porcelain gallbladder and gallbladder cancer has been challenged (<LINK REF="REF-Towfigh-2001" TYPE="REFERENCE">Towfigh 2001</LINK>), prophylactic cholecystectomy is currently recommended for porcelain gallbladder (<LINK REF="REF-NIH-1992" TYPE="REFERENCE">NIH 1992</LINK>). Gallbladder polyps or suspected gallbladder polyps, more than 10 mm in size, have also been found to be associated with gallbladder cancer (<LINK REF="REF-Okamoto-1999" TYPE="REFERENCE">Okamoto 1999</LINK>; <LINK REF="REF-Lee-2004" TYPE="REFERENCE">Lee 2004</LINK>; <LINK REF="REF-Chattopadhyay-2005" TYPE="REFERENCE">Chattopadhyay 2005</LINK>) and may be an indication for cholecystectomy. Cholecystectomy in the absence of symptoms is also controversial in diabetics, in immunosuppressed, and in children. Currently, there is no clear evidence to support prophylactic cholecystectomy in these groups, ie, in diabetics (<LINK REF="REF-Del-Favero-1994" TYPE="REFERENCE">Del Favero 1994</LINK>), in immunosuppressed (<LINK REF="REF-NIH-1992" TYPE="REFERENCE">NIH 1992</LINK>; <LINK REF="REF-Jackson-2005" TYPE="REFERENCE">Jackson 2005</LINK>), in children (<LINK REF="REF-NIH-1992" TYPE="REFERENCE">NIH 1992</LINK>), or in any other group.</P>
<P>Thus, surgery for silent gallstones represents a therapeutic dilemma (<LINK REF="REF-Gibney-1990" TYPE="REFERENCE">Gibney 1990</LINK>; <LINK REF="REF-Bittner-2004" TYPE="REFERENCE">Bittner 2004</LINK>; <LINK REF="REF-Gupta-2004" TYPE="REFERENCE">Gupta 2004</LINK>), but should be considered for the following reasons:<BR/>(1) Complications associated with gallstones.<BR/>(a) Pancreatitis. Gallstone is one of the important aetiological factors for acute pancreatitis responsible for nearly 45% of acute severe pancreatitis (<LINK REF="REF-Gloor-2001" TYPE="REFERENCE">Gloor 2001</LINK>). Acute pancreatitis has a mortality rate of 10% (<LINK REF="REF-Corfield-1985" TYPE="REFERENCE">Corfield 1985</LINK>; <LINK REF="REF-Mann-1994" TYPE="REFERENCE">Mann 1994</LINK>). At present there are no clear predictive factors of the risk of pancreatitis from the size of the gallstone or motility of gallbladder (<LINK REF="REF-Venneman-2005" TYPE="REFERENCE">Venneman 2005</LINK>).<BR/>(b) Cholecystitis (<LINK REF="REF-NIH-1992" TYPE="REFERENCE">NIH 1992</LINK>).<BR/>(c) Obstructive jaundice. Treatment for common bile duct stones may involve open common bile duct exploration (<LINK REF="REF-Sarli-2003" TYPE="REFERENCE">Sarli 2003</LINK>) or laparoscopic exploration (<LINK REF="REF-Hyser-1999" TYPE="REFERENCE">Hyser 1999</LINK>; <LINK REF="REF-Rojas_x002d_Ortega-2003" TYPE="REFERENCE">Rojas-Ortega 2003</LINK>; <LINK REF="REF-Waage-2003" TYPE="REFERENCE">Waage 2003</LINK>; <LINK REF="REF-Ebner-2004" TYPE="REFERENCE">Ebner 2004</LINK>) or endoscopic retrograde cholangiopancreatography (ERCP) (<LINK REF="REF-Cuschieri-1999" TYPE="REFERENCE">Cuschieri 1999</LINK>; <LINK REF="REF-Turcu-2000" TYPE="REFERENCE">Turcu 2000</LINK>; <LINK REF="REF-Huttl-2002" TYPE="REFERENCE">Huttl 2002</LINK>; <LINK REF="REF-Ludwig-2002" TYPE="REFERENCE">Ludwig 2002</LINK>; <LINK REF="REF-Enochsson-2004" TYPE="REFERENCE">Enochsson 2004</LINK>), all of which carry morbidity (<LINK REF="REF-Wills-2002" TYPE="REFERENCE">Wills 2002</LINK>; <LINK REF="REF-Christensen-2004" TYPE="REFERENCE">Christensen 2004</LINK>).<BR/>(d) Gallbladder cancer. Studies have shown a high degree of correlation between gallstones and gallbladder cancer (<LINK REF="REF-Black-1977" TYPE="REFERENCE">Black 1977</LINK>; <LINK REF="REF-Amir-1990" TYPE="REFERENCE">Amir 1990</LINK>; <LINK REF="REF-Launoy-1993" TYPE="REFERENCE">Launoy 1993</LINK>; <LINK REF="REF-Okamoto-1999" TYPE="REFERENCE">Okamoto 1999</LINK>). Some studies have shown that the relative risk for gallbladder cancer is about 4.4 in the presence of gallstones (<LINK REF="REF-Lowenfels-1985" TYPE="REFERENCE">Lowenfels 1985</LINK>). Other studies have questioned prophylactic cholecystectomy on the grounds that only 11% of the patients with gallbladder cancer had gallstones for more than one year (<LINK REF="REF-Broden-1980" TYPE="REFERENCE">Broden 1980</LINK>).<BR/>(2) Studies have shown that laparoscopic cholecystectomy, performed in persons with asymptomatic gallstones, has significantly lower morbidity rates, conversion rates, and operating time as compared to that performed in patients with symptomatic gallstones (<LINK REF="REF-Yano-2003" TYPE="REFERENCE">Yano 2003</LINK>).<BR/>(3) Studies have shown that the morbidity of laparoscopic cholecystectomy increases with age (<LINK REF="REF-Bittner-2004" TYPE="REFERENCE">Bittner 2004</LINK>).</P>
<P>However, cholecystectomy is not without risks (<LINK REF="REF-Keus-2006" TYPE="REFERENCE">Keus 2006</LINK>). The risks include:<BR/>(1) Mortality due to the various complications.<BR/>(2) Injury to vessels or bowel (<LINK REF="REF-Fletcher-1999" TYPE="REFERENCE">Fletcher 1999</LINK>) during port insertion for laparoscopic cholecystectomy.<BR/>(3) Bile duct injury. The reported incidence of bile duct injury is between 0.3% (<LINK REF="REF-Richardson-1996" TYPE="REFERENCE">Richardson 1996</LINK>; <LINK REF="REF-Krahenbuhl-2001" TYPE="REFERENCE">Krahenbuhl 2001</LINK>) and 1% (<LINK REF="REF-Buanes-1996" TYPE="REFERENCE">Buanes 1996</LINK>). Major bile duct injuries can even cause death due to uncontrolled sepsis (<LINK REF="REF-Sicklick-2005" TYPE="REFERENCE">Sicklick 2005</LINK>). Corrective surgery for bile duct injury carries its own risks including mortality (<LINK REF="REF-Schmidt-2005" TYPE="REFERENCE">Schmidt 2005</LINK>; <LINK REF="REF-Sicklick-2005" TYPE="REFERENCE">Sicklick 2005</LINK>), bile leak (<LINK REF="REF-Schmidt-2005" TYPE="REFERENCE">Schmidt 2005</LINK>; <LINK REF="REF-Sicklick-2005" TYPE="REFERENCE">Sicklick 2005</LINK>), cholangitis (<LINK REF="REF-Johnson-2000" TYPE="REFERENCE">Johnson 2000</LINK>; <LINK REF="REF-Schmidt-2005" TYPE="REFERENCE">Schmidt 2005</LINK>; <LINK REF="REF-Sicklick-2005" TYPE="REFERENCE">Sicklick 2005</LINK>), biliary stricture (<LINK REF="REF-Johnson-2000" TYPE="REFERENCE">Johnson 2000</LINK>; <LINK REF="REF-Huang-2003" TYPE="REFERENCE">Huang 2003</LINK>; <LINK REF="REF-Schmidt-2005" TYPE="REFERENCE">Schmidt 2005</LINK>), and biliary cirrhosis (<LINK REF="REF-Schmidt-2005" TYPE="REFERENCE">Schmidt 2005</LINK>).<BR/>(4) Bile leak requiring ERCP (<LINK REF="REF-Johansson-2003" TYPE="REFERENCE">Johansson 2003</LINK>; <LINK REF="REF-Kimura-2005" TYPE="REFERENCE">Kimura 2005</LINK>). ERCP has its own risks of mortality, pancreatitis, haemorrhage, and perforation (<LINK REF="REF-Christensen-2004" TYPE="REFERENCE">Christensen 2004</LINK>).</P>
<P>The alternative treatments for gallstones are dissolution of stones by oral bile acids alone or in combination with other drugs (<LINK REF="REF-Tuncer-2003" TYPE="REFERENCE">Tuncer 2003</LINK>), contact dissolution using methyl-terbutyl ether (<LINK REF="REF-Hellstern-1998" TYPE="REFERENCE">Hellstern 1998</LINK>) or ethyl propionate (<LINK REF="REF-Zakko-1997" TYPE="REFERENCE">Zakko 1997</LINK>), or shockwave lithotripsy with or without bile acids (<LINK REF="REF-Ertan-1992" TYPE="REFERENCE">Ertan 1992</LINK>; <LINK REF="REF-Sauter-1997" TYPE="REFERENCE">Sauter 1997</LINK>). However, these treatments leave the gallbladder behind and recurrence of gallstones is common (<LINK REF="REF-Avci-1993" TYPE="REFERENCE">Avci 1993</LINK>; <LINK REF="REF-Sackmann-1994" TYPE="REFERENCE">Sackmann 1994</LINK>; <LINK REF="REF-Pauletzki-1995" TYPE="REFERENCE">Pauletzki 1995</LINK>; <LINK REF="REF-Hellstern-1998" TYPE="REFERENCE">Hellstern 1998</LINK>; <LINK REF="REF-Cesmeli-1999" TYPE="REFERENCE">Cesmeli 1999</LINK>). Primary treatment failure is common (<LINK REF="REF-Petroni-1995" TYPE="REFERENCE">Petroni 1995</LINK>), and prolonged treatment is needed for complete dissolution of stones (<LINK REF="REF-Tuncer-2003" TYPE="REFERENCE">Tuncer 2003</LINK>).</P>
<P>We have not been able to identify any systematic reviews or meta-analyses comparing cholecystectomy versus no cholecystectomy for patients with asymptomatic gallstones.</P>
</BACKGROUND>
<OBJECTIVES>
<P>To assess the benefits and harms of prophylactic cholecystectomy in patients with asymptomatic gallstones.</P>
</OBJECTIVES>
<METHODS MODIFIED="2008-10-17 15:52:41 +0100" MODIFIED_BY="dimitrinka nikolova">
<SELECTION_CRITERIA MODIFIED="2008-09-04 16:01:05 +0100" MODIFIED_BY="dimitrinka nikolova">
<CRIT_STUDIES>
<P>Only randomised clinical trials (irrespective of language, blinding, or publication status) were to be considered for this review.</P>
<P>Quasi-randomised studies (where the method of allocating participants to a treatment are not strictly random, eg, date of birth, hospital record number, alternation), cohort studies, and case-control studies were to be excluded from this review.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Patients who have asymptomatic gallstones. Patients with symptoms including cholecystitis, pancreatitis, obstructive jaundice, and biliary colic were excluded from the review.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2008-09-04 15:48:47 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>We were to include only trials comparing cholecystectomy (whether performed through an open access or laparoscopic access) versus no cholecystectomy.</P>
<P>The following types of trials were excluded.</P>
<OL>
<LI>Trials comparing cholecystectomy versus medical treatment.</LI>
<LI>Trials comparing medical treatment versus no treatment.</LI>
<LI>Trials comparing open cholecystectomy versus laparoscopic cholecystectomy.</LI>
</OL>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2008-09-04 16:01:05 +0100" MODIFIED_BY="dimitrinka nikolova">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2008-09-04 16:01:05 +0100" MODIFIED_BY="dimitrinka nikolova">
<OL>
<LI>Mortality (at maximal follow-up).</LI>
<LI>Bile duct injury.</LI>
<LI>Acute severe pancreatitis.</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2008-09-04 16:01:05 +0100" MODIFIED_BY="dimitrinka nikolova">
<OL>
<LI>Cholecystitis.</LI>
<LI>Obstructive jaundice.</LI>
<LI>Bile leak requiring drainage:</LI>
<OL>
<LI>Surgical drainage,</LI>
<LI>Image guided drain insertion,</LI>
<LI>Image guided aspiration.</LI>
</OL>
<LI>Bile leak requiring ERCP.</LI>
<LI>Other morbidity such as wound infection, intra-abdominal collections requiring drainage, infected intra-abdominal collections.</LI>
<LI>Number of hospital admissions (for complications or treatment of complications of gallstones).</LI>
<LI>Length of stay (for surgery, complications, or treatment of complications of gallstones).</LI>
<LI>Gallbladder cancer.</LI>
<LI>Number of workdays lost (because of surgery or because of symptoms).</LI>
<LI>Quality-of-life measures (however reported by authors).</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2008-10-17 15:48:07 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>We searched <I>The Cochrane Hepato-Biliary Group Controlled Trials Register</I>, the<I> Cochrane Central Register of Controlled Trials </I>(<I>CENTRAL</I>)<I> </I>in <I>The Cochrane Library</I>, <I>MEDLINE</I>, <I>EMBASE,</I> and <I>Science Citation Index Expanded </I>until May 2008 (<LINK REF="REF-Royle-2003" TYPE="REFERENCE">Royle 2003</LINK>). We have given the search strategies with the timespan for the searches in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
<P>References of the identified studies were also searched for identifying studies of possible interest.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2008-10-17 15:52:41 +0100" MODIFIED_BY="dimitrinka nikolova">
<SUBSECTION>
<HEADING LEVEL="3">Study selection and extraction of data</HEADING>
<P>Both authors independently of each other identified the studies for possible inclusion. The excluded studies conducted on the relevant population with the reasons for the exclusion were to be listed in 'Excluded studies'. There were no differences in opinion.</P>
<P>Both authors had planned to independently extract the following data:</P>
<OL>
<LI>Year and language of publication.</LI>
<LI>Country.</LI>
<LI>Year of study.</LI>
<LI>Inclusion and exclusion criteria.</LI>
<LI>Sample size.</LI>
<LI>Population characteristics such as age and sex.</LI>
<LI>Open or laparoscopic cholecystectomy.</LI>
<LI>Peri-operative antibiotics.</LI>
<LI>Drain used or not.</LI>
<LI>Outcomes (mentioned above).</LI>
<LI>Methodological quality (described below).</LI>
</OL>
<P>Any unclear or missing information was to be sought by contacting the authors of the individual trials. We planned to contact the authors of the reports of the trials if there was any doubt whether the trials shared the same patients - completely or partially (by identifying common authors and centres) to clarify whether the report had been duplicated.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Assessment of methodological quality</HEADING>
<P>We had planned to assess the methodological quality of the trials independently, without masking of the study names should we have found trials for inclusion. We had planned to follow the instructions given in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>) and <I>The Cochrane Hepato-Biliary Group Module</I> (<LINK REF="REF-Gluud-2008" TYPE="REFERENCE">Gluud 2008</LINK>). Due to the risk of overestimation of intervention effects in randomised trials with inadequate methodological quality (<LINK REF="REF-Schulz-1995" TYPE="REFERENCE">Schulz 1995</LINK>; <LINK REF="REF-Moher-1998" TYPE="REFERENCE">Moher 1998</LINK>; <LINK REF="REF-Kjaergard-2001" TYPE="REFERENCE">Kjaergard 2001</LINK>; <LINK REF="REF-Wood-2008" TYPE="REFERENCE">Wood 2008</LINK>), we had planned to look at the influence of methodological quality of the trials on the trial results by evaluating the reported randomisation and follow-up procedures in each trial. If information was not available in the published trial, we intended to contact the authors in order to assess the trials correctly. We had planned to assess generation of allocation sequence, allocation concealment, blinding, and follow-up.</P>
<SUBSECTION>
<HEADING LEVEL="4">
<I>Generation of the allocation sequence</I>
</HEADING>
<UL>
<LI>Adequate, if the allocation sequence was generated by a computer or random number table. Drawing of lots, tossing of a coin, shuffling of cards, or throwing dice will be considered as adequate if a person who was not otherwise involved in the recruitment of participants performed the procedure.</LI>
<LI>Unclear, if the trial was described as randomised, but the method used for the allocation sequence generation was not described. (The authors will be contacted and attempts will be made to find out the allocation method.)</LI>
<LI>Inadequate, if a system involving dates, names, or admittance numbers were used for the allocation of patients. These studies are known as quasi-randomised and we planned to exclude them from the review.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">
<I>Allocation concealment</I>
</HEADING>
<UL>
<LI>Adequate, if the allocation of patients involved a central independent unit, on-site locked computer, or sealed envelopes.</LI>
<LI>Unclear, if the trial was described as randomised, but the method used to conceal the allocation was not described.</LI>
<LI>Inadequate, if the allocation sequence was known to the investigators who assigned participants or if the study was quasi-randomised. We planned to exclude such trials from the review.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">
<I>Blinding</I>
</HEADING>
<P>We did not plan to assess double blinding as it is not possible to blind the patients. The health-care providers (the surgeons) would have to be informed of any complications that occurred during the waiting period in order to assess the appropriate treatment required for the patient. However, it is possible to blind the observers for outcomes such as quality of life. We planned to consider blinding to be adequate if observer blinding was performed.</P>
<UL>
<LI>Adequate, if the outcome assessors were blinded and the method of blinding was described.</LI>
<LI>Unclear, if the outcome assessors were blinded and the method of blinding was not described.</LI>
<LI>Not performed, if the outcome assessors were not blinded.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">
<I>Incomplete data outcomes</I>
</HEADING>
<UL>
<LI>Adequate, if there were no post-randomisation drop-outs or withdrawals or if the post-randomisation drop-outs were balanced in both groups or reasons for missing data unlikely to be related to true outcome.</LI>
<LI>Unclear, if it is not clear whether there are any drop-outs or withdrawals or if the reasons for these drop-outs are not clear.</LI>
<LI>Inadequate, if the reasons for missing data are likely to be related to true outcomes, "as-treated" analysis was performed, potentially inappropriate application of simple imputation, potential for patients with missing outcomes to induce clinically relevant bias in effect estimate or effect size.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">
<I>Selective outcome reporting</I>
</HEADING>
<UL>
<LI>Adequate, if all the important outcomes were reported or if the study protocol was available and all of the study&#8217;s pre-specified (primary and secondary) outcomes that are of interest in the review have been reported in the pre-specified way.</LI>
<LI>Unclear, if there is insufficient information to assess whether the risk of selective outcome reporting is present.</LI>
<LI>Inadequate, if not all the pre-specified outcomes were reported or if the primary outcomes were changed or if some of the important outcomes were incompletely reported.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">
<I>Other biases</I>
</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Baseline imbalance</HEADING>
<UL>
<LI>Adequate, if there was no baseline imbalance in important characteristics.</LI>
<LI>Unclear, if the baseline characteristics were not reported.</LI>
<LI>Inadequate, if there was an baseline imbalance due to chance or due to imbalanced exclusion after randomisation.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Early stopping</HEADING>
<UL>
<LI>Adequate, if sample size calculation was reported and the trial was not stopped or the trial was stopped early by a formal stopping rule at a point where the likelihood of observing an extreme intervention effect due to chance was low.</LI>
<LI>Unclear, if sample size calculation was not reported and it is not clear whether the trial was stopped early or not.</LI>
<LI>Inadequate, the trial was stopped early due to an informal stopping rule or the trial was stopped early by a formal stopping rule at a point where the likelihood of observing an extreme intervention effect due to chance was high.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Blocked randomisation in unblinded trials</HEADING>
<UL>
<LI>Adequate, if blocked randomisation was used or blinding was adequate or if the blocks were of variable size or if the blocks were distributed across multiple centres such that it is not possible to predict the block size in a single centre.</LI>
<LI>Unclear, if the method of blocked randomisation was not described.</LI>
<LI>Inadequate, if it was possible to predict future assignments of participants based on previous assignments such as when fixed size blocks were used in a centre when the blinding was inadequate.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Source of funding</HEADING>
<UL>
<LI>Adequate, if the trial was unfunded or was not funded by an instrument manufacturer.</LI>
<LI>Unclear, if the source of funding was not clear.</LI>
<LI>Inadequate, if the trial was funded by an instrument manufacturer.</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Statistical methods</HEADING>
<P>We planned to perform the meta-analyses according to the recommendations of The Cochrane Collaboration (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>). We planned to use the software package <LINK REF="REF-RevMan-2008" TYPE="REFERENCE">RevMan 2008</LINK>. For dichotomous variables, we planned to calculate the risk ratio with 95% confidence interval. We planned to use a random-effects model (<LINK REF="REF-DerSimonian-1986" TYPE="REFERENCE">DerSimonian 1986</LINK>) and a fixed-effect model (<LINK REF="REF-Demets-1987" TYPE="REFERENCE">Demets 1987</LINK>). In case of discrepancy between the two models we would have reported both results; otherwise we planned to report only the results from the fixed-effect model.</P>
<P>We planned to perform subgroup analyses depending on the methodological quality of the trials in order to compare the intervention effect in trials with adequate methodological quality to that of trials with unclear or inadequate methodological quality. We planned to explore heterogeneity by chi-squared test with significance set at P value 0.10, and measure the quantity of heterogeneity by I<SUP>2</SUP> (<LINK REF="REF-Higgins-2002" TYPE="REFERENCE">Higgins 2002</LINK>).</P>
<P>Whenever possible, we planned to performed the analysis on an intention-to-treat basis (<LINK REF="REF-Newell-1992" TYPE="REFERENCE">Newell 1992</LINK>). Otherwise, we planned to perform 'available case analysis'. We planned to perform a sensitivity analysis with and without empirical continuity correction factors as suggested by Sweeting et al in case we found 'zero-event' trials (<LINK REF="REF-Sweeting-2004" TYPE="REFERENCE">Sweeting 2004</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup analysis</HEADING>
<P>We planned to perform the following subgroup analyses:<BR/>- trials with high (adequate allocation concealment) compared to trials with low methodological quality (unclear allocation concealment).<BR/>- trials using blinded outcome assessment to trials with blinded outcome assessment.<BR/>- laparoscopic versus open cholecystectomy.<BR/>- trials that use routine antibiotic prophylaxis (for surgery) compared to those that do not use routine antibiotic prophylaxis.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Bias exploration</HEADING>
<P>We planned to use a funnel plot to explore publication bias and other bias (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>; <LINK REF="REF-Macaskill-2001" TYPE="REFERENCE">Macaskill 2001</LINK>). Asymmetry in funnel plot of study size against treatment effect was to be used to identify this bias. We also planned to perform linear regression approach described by Egger to determine the funnel plot asymmetry (<LINK REF="REF-Egger-1997" TYPE="REFERENCE">Egger 1997</LINK>).</P>
</SUBSECTION>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2008-09-04 16:01:05 +0100" MODIFIED_BY="dimitrinka nikolova">
<STUDY_DESCRIPTION MODIFIED="2008-09-04 16:01:05 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>We identified a total of 667 references through electronic searches of <I>The Cochrane Hepato-Biliary Group Controlled Trials Register</I> and the <I>Cochrane Central Register of Controlled Trials</I> (<I>CENTRAL</I>) in <I>The Cochrane Library</I> (n = 103), <I>MEDLINE</I> (n = 363), <I>EMBASE</I> (n = 160), and <I>Science Citation Index Expanded</I> (n = 41). We excluded 209 duplicates and the remaining 458 references after having read titles and abstracts.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2008-09-04 15:55:06 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>None of the studies identified through the search strategy qualified for inclusion in this review. We were also unable to identify any cohort studies or any case-control studies that could meaningfully try to answer the questions posed in this systematic review.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS>
<P>None of the studies identified through the search strategy qualified for this review. </P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2008-09-04 16:01:05 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>None of the studies identified through the search strategy qualified for this review. We were also unable to identify non-randomised studies, which could give information to answer the posed question. Accordingly, we have been unable to identify evidence, which could guide us. Therefore, there seems to be an urgent need for studies on whether to perform cholecystectomy in patients with asymptomatic gallstones. Ethical considerations of exposing 100 patients to the risk of surgery to prevent gallstone-associated complications in 10 to 15 patients (ie, exposing 85 to 90 patients to the risks of surgery unnecessarily) has to be considered before designing randomised trials to compare cholecystectomy versus no cholecystectomy. Studies, in which prophylactic cholecystectomy was performed for asymptomatic gallstones based on patient's preference (as some patients may prefer to have their gallbladders removed when all the facts are told to them), might throw some light into this issue. Also, further evaluation of the studies in which cholecystectomy was performed routinely and those in which cholecystectomy was not performed for asymptomatic gallstones has to be performed. The follow-up of these studies should be of sufficient duration to demonstrate a reduction in the incidence of obstructive jaundice, gallstone-associated pancreatitis, and/or gallbladder cancer to justify the exposure of the patients with asymptomatic gallstones to the complications of surgery in the trial.</P>
</DISCUSSION>
<CONCLUSIONS>
<IMPLICATIONS_PRACTICE>
<P>There is no evidence in literature to either recommend or refuse surgery to patients with asymptomatic gallstones.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH>
<P>Observational studies, which measure outcomes such as obstructive jaundice, gallstone-associated pancreatitis, and/or gallbladder cancer for sufficient duration of follow-up is necessary. Such studies could help to determine the dimension and duration of follow-up of randomised clinical trials designed to evaluate whether cholecystectomy or no cholecystectomy is better for asymptomatic gallstones.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2008-09-04 15:56:07 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>(1) To Martyn Parker, author of more than 15 Cochrane reviews, who inspired me to write Cochrane reviews.<BR/>(2) To Brian Davidson who encourages and supports me in the preparation of Cochrane reviews.<BR/>(3) To The Cochrane Hepato-Biliary Group for the support that they have provided.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2008-10-17 15:53:18 +0100" MODIFIED_BY="dimitrinka nikolova">
<P>KS Gurusamy prepared the review and assessed the trials for inclusion. K Samraj is the co-author of the protocol and independently assessed the trials for inclusion and contributed to the discussion.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2008-10-17 16:22:56 +0100" MODIFIED_BY="dimitrinka nikolova">
<SUBSECTION>
<HEADING LEVEL="2">Differences between the protocol and the updated review (Issue 1 2009)</HEADING>
<P>We updated the components for assessing the risk of bias of the trials in line with the recommendations of the updated Cochrane Handbook in 2008. We included two additional secondary outcomes:<BR/>- other morbidity such as wound infection, intra-abdominal collections requiring drainage, infected intra-abdominal collections <BR/>and<BR/>- number of workdays lost (because of surgery or because of symptoms).</P>
</SUBSECTION>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova">
<STUDIES>
<INCLUDED_STUDIES/>
<EXCLUDED_STUDIES/>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova">
<ADDITIONAL_REFERENCES MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova">
<REFERENCE ID="REF-Amir-1990" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Amir 1990" TYPE="JOURNAL_ARTICLE">
<AU>Amir H, Kirei B</AU>
<TI>Primary carcinoma of gallbladder in Tanzania. A twenty-year review</TI>
<SO>The Central African Journal of Medicine</SO>
<YR>1990</YR>
<VL>36</VL>
<NO>7</NO>
<PG>164-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Avci-1993" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Avci 1993" TYPE="JOURNAL_ARTICLE">
<AU>Avci G, Bora S, Erdamar I, Fuzun M, Harmancioglu O</AU>
<TI>Gallstone recurrence after shock wave therapy</TI>
<SO>Surgery Gynecology Obstetrics</SO>
<YR>1993</YR>
<VL>177</VL>
<NO>6</NO>
<PG>598-600</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bittner-2004" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Bittner 2004" TYPE="JOURNAL_ARTICLE">
<AU>Bittner R, Ulrich M</AU>
<TI>Gallbladder calculi - always an indication for surgery?</TI>
<TO>Gallenblasensteinleiden - immer eine Operationsindikation?</TO>
<SO>Der Internist</SO>
<YR>2004</YR>
<VL>45</VL>
<NO>1</NO>
<PG>8-15</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Black-1977" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Black 1977" TYPE="JOURNAL_ARTICLE">
<AU>Black WC, Key CR, Carmany TB, Herman D</AU>
<TI>Carcinoma of the gallbladder in a population of Southwestern American Indians</TI>
<SO>Cancer</SO>
<YR>1977</YR>
<VL>39</VL>
<NO>3</NO>
<PG>1267-79</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Broden-1980" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Broden 1980" TYPE="JOURNAL_ARTICLE">
<AU>Broden G, Bengtsson L</AU>
<TI>Carcinoma of the gallbladder. Its relation to cholelithiasis and to the concept of prophylactic cholecystectomy</TI>
<SO>Acta Chirurgica Scandinavica. Supplementum</SO>
<YR>1980</YR>
<VL>500</VL>
<PG>15-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Buanes-1996" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Buanes 1996" TYPE="JOURNAL_ARTICLE">
<AU>Buanes T, Waage A, Mjaland O, Solheim K</AU>
<TI>Bile leak after cholecystectomy significance and treatment: results from the National Norwegian Cholecystectomy Registry</TI>
<SO>International Surgery</SO>
<YR>1996</YR>
<VL>81</VL>
<NO>3</NO>
<PG>276-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cesmeli-1999" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Cesmeli 1999" TYPE="JOURNAL_ARTICLE">
<AU>Cesmeli E, Elewaut AE, Kerre T, De Buyzere M, Afschrift M, Elewaut A</AU>
<TI>Gallstone recurrence after successful shock wave therapy: the magnitude of the problem and the predictive factors</TI>
<SO>American Journal of Gastroenterology</SO>
<YR>1999</YR>
<VL>94</VL>
<NO>2</NO>
<PG>474-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chattopadhyay-2005" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Chattopadhyay 2005" TYPE="JOURNAL_ARTICLE">
<AU>Chattopadhyay D, Lochan R, Balupuri S, Gopinath BR, Wynne KS</AU>
<TI>Outcome of gall bladder polypoidal lesions detected by transabdominal ultrasound scanning: a nine year experience</TI>
<SO>World Journal of Gastroenterology</SO>
<YR>2005</YR>
<VL>11</VL>
<NO>14</NO>
<PG>2171-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Christensen-2004" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Christensen 2004" TYPE="JOURNAL_ARTICLE">
<AU>Christensen M, Matzen P, Schulze S, Rosenberg J</AU>
<TI>Complications of ERCP: a prospective study</TI>
<SO>Gastrointestinal Endoscopy</SO>
<YR>2004</YR>
<VL>60</VL>
<NO>5</NO>
<PG>721-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Corfield-1985" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Corfield 1985" TYPE="JOURNAL_ARTICLE">
<AU>Corfield AP, Cooper MJ, Williamson RC</AU>
<TI>Acute pancreatitis: a lethal disease of increasing incidence</TI>
<SO>Gut</SO>
<YR>1985</YR>
<VL>26</VL>
<NO>7</NO>
<PG>724-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cuschieri-1999" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Cuschieri 1999" TYPE="JOURNAL_ARTICLE">
<AU>Cuschieri A, Lezoche E, Morino M, Croce E, Lacy A, Toouli J, et al</AU>
<TI>E.A.E.S. multicenter prospective randomized trial comparing two-stage vs single-stage management of patients with gallstone disease and ductal calculi</TI>
<SO>Surgical Endoscopy</SO>
<YR>1999</YR>
<VL>13</VL>
<NO>10</NO>
<PG>952-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Del-Favero-1994" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Del Favero 1994" TYPE="JOURNAL_ARTICLE">
<AU>Del Favero G, Caroli A, Meggiato T, Volpi A, Scalon P, Puglisi A, et al</AU>
<TI>Natural history of gallstones in non-insulin-dependent diabetes mellitus. A prospective 5-year follow-up</TI>
<SO>Digestive Diseases and Sciences</SO>
<YR>1994</YR>
<VL>39</VL>
<NO>8</NO>
<PG>1704-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Demets-1987" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Demets 1987" TYPE="JOURNAL_ARTICLE">
<AU>Demets DL</AU>
<TI>Methods for combining randomized clinical trials: strengths and limitations</TI>
<SO>Statistics in Medicine</SO>
<YR>1987</YR>
<VL>6</VL>
<NO>3</NO>
<PG>341-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-DerSimonian-1986" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="DerSimonian 1986" TYPE="JOURNAL_ARTICLE">
<AU>DerSimonian R, Laird N</AU>
<TI>Meta-analysis in clinical trials</TI>
<SO>Controlled Clinical Trials</SO>
<YR>1986</YR>
<VL>7</VL>
<NO>3</NO>
<PG>177-88</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Duensing-2000" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Duensing 2000" TYPE="JOURNAL_ARTICLE">
<AU>Duensing RA, Williams RA, Collins JC, Wilson SE</AU>
<TI>Common bile duct stone characteristics: correlation with treatment choice during laparoscopic cholecystectomy</TI>
<SO>Journal of Gastrointestinal Surgery</SO>
<YR>2000</YR>
<VL>4</VL>
<NO>1</NO>
<PG>6-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ebner-2004" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Ebner 2004" TYPE="JOURNAL_ARTICLE">
<AU>Ebner S, Rechner J, Beller S, Erhart K, Riegler FM, Szinicz G</AU>
<TI>Laparoscopic management of common bile duct stones</TI>
<SO>Surgical Endoscopy</SO>
<YR>2004</YR>
<VL>18</VL>
<NO>5</NO>
<PG>762-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Egger-1997" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Egger 1997" TYPE="JOURNAL_ARTICLE">
<AU>Egger M, Davey Smith G, Schneider M, Minder C</AU>
<TI>Bias in meta-analysis detected by a simple, graphical test</TI>
<SO>BMJ (Clinical Research Ed.)</SO>
<YR>1997</YR>
<VL>315</VL>
<NO>7109</NO>
<PG>629-34</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Enochsson-2004" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Enochsson 2004" TYPE="JOURNAL_ARTICLE">
<AU>Enochsson L, Lindberg B, Swahn F, Arnelo U</AU>
<TI>Intraoperative endoscopic retrograde cholangiopancreatography (ERCP) to remove common bile duct stones during routine laparoscopic cholecystectomy does not prolong hospitalization: a 2-year experience</TI>
<SO>Surgical Endoscopy</SO>
<YR>2004</YR>
<VL>18</VL>
<NO>3</NO>
<PG>367-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ertan-1992" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Ertan 1992" TYPE="JOURNAL_ARTICLE">
<AU>Ertan A, Hernandez RE, Campeau RJ, Geshner JR, Litwin MS</AU>
<TI>Extracorporeal shock-wave lithotripsy and ursodiol versus ursodiol alone in the treatment of gallstones</TI>
<SO>Gastroenterology</SO>
<YR>1992</YR>
<VL>103</VL>
<NO>1</NO>
<PG>311-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fletcher-1999" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Fletcher 1999" TYPE="JOURNAL_ARTICLE">
<AU>Fletcher DR, Hobbs MS, Tan P, Valinsky LJ, Hockey RL, Pikora TJ, et al</AU>
<TI>Complications of cholecystectomy: risks of the laparoscopic approach and protective effects of operative cholangiography: a population-based study</TI>
<SO>Annals of Surgery</SO>
<YR>1999</YR>
<VL>229</VL>
<NO>4</NO>
<PG>449-57</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fullarton-1994" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Fullarton 1994" TYPE="JOURNAL_ARTICLE">
<AU>Fullarton GM, Bell G</AU>
<TI>Prospective audit of the introduction of laparoscopic cholecystectomy in the west of Scotland. West of Scotland Laparoscopic Cholecystectomy Audit Group</TI>
<SO>Gut</SO>
<YR>1994</YR>
<VL>35</VL>
<NO>8</NO>
<PG>1121-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gibney-1990" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Gibney 1990" TYPE="JOURNAL_ARTICLE">
<AU>Gibney EJ</AU>
<TI>Asymptomatic gallstones</TI>
<SO>The British Journal of Surgery</SO>
<YR>1990</YR>
<VL>77</VL>
<NO>4</NO>
<PG>368-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gloor-2001" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Gloor 2001" TYPE="JOURNAL_ARTICLE">
<AU>Gloor B, Muller CA, Worni M, Martignoni ME, Uhl W, Buchler MW</AU>
<TI>Late mortality in patients with severe acute pancreatitis</TI>
<SO>The British Journal of Surgery</SO>
<YR>2001</YR>
<VL>88</VL>
<NO>7</NO>
<PG>975-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gluud-2008" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Gluud 2008" TYPE="OTHER">
<AU>Gluud C, Nikolova D, Klingenberg SL, Whitfield K, Alexakis N, Als-Nielsen B, et al</AU>
<TI>Cochrane Hepato-Biliary Group</TI>
<SO>About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2008, Issue 3. Art. No.: LIVER</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gupta-2004" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Gupta 2004" TYPE="JOURNAL_ARTICLE">
<AU>Gupta SK, Shukla VK</AU>
<TI>Silent gallstones: a therapeutic dilemma</TI>
<SO>Tropical Gastroenterology</SO>
<YR>2004</YR>
<VL>25</VL>
<NO>2</NO>
<PG>65-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Halldestam-2004" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Halldestam 2004" TYPE="JOURNAL_ARTICLE">
<AU>Halldestam I, Enell EL, Kullman E, Borch K</AU>
<TI>Development of symptoms and complications in individuals with asymptomatic gallstones</TI>
<SO>The British Journal of Surgery</SO>
<YR>2004</YR>
<VL>91</VL>
<NO>6</NO>
<PG>734-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hellstern-1998" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Hellstern 1998" TYPE="JOURNAL_ARTICLE">
<AU>Hellstern A, Leuschner U, Benjaminov A, Ackermann H, Heine T, Festi D, et al</AU>
<TI>Dissolution of gallbladder stones with methyl tert-butyl ether and stone recurrence: a European survey</TI>
<SO>Digestive Diseases and Sciences</SO>
<YR>1998</YR>
<VL>43</VL>
<NO>5</NO>
<PG>911-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hemli-2004" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Hemli 2004" TYPE="JOURNAL_ARTICLE">
<AU>Hemli JM, Arnot RS, Ashworth JJ, Curtin AM, Simon RA, Townend DM</AU>
<TI>Feasibility of laparoscopic common bile duct exploration in a rural centre</TI>
<SO>ANZ Journal of Surgery</SO>
<YR>2004</YR>
<VL>74</VL>
<NO>11</NO>
<PG>979-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2002" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Higgins 2002" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JP, Thompson SG</AU>
<TI>Quantifying heterogeneity in a meta-analysis</TI>
<SO>Statistics in Medicine</SO>
<YR>2002</YR>
<VL>21</VL>
<NO>11</NO>
<PG>1539-58</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Higgins 2008" TYPE="BOOK">
<AU>Higgins JPT, Green S (editors)</AU>
<SO>Cochrane Handbook for Systematic Reviews of Intervention 5.0.0 [updated February 2008]</SO>
<YR>2008. Available from www.cochrane-handbook.org</YR>
<PB>The Cochrane Colloboration</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Huang-2003" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Huang 2003" TYPE="JOURNAL_ARTICLE">
<AU>Huang CS, Lein HH, Tai FC, Wu CH</AU>
<TI>Long-term results of major bile duct injury associated with laparoscopic cholecystectomy</TI>
<SO>Surgical Endoscopy</SO>
<YR>2003</YR>
<VL>17</VL>
<NO>9</NO>
<PG>1362-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Huttl-2002" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Huttl 2002" TYPE="JOURNAL_ARTICLE">
<AU>Huttl TP, Hrdina C, Geiger TK, Meyer G, Schildberg FW, Kramling HJ</AU>
<TI>Management of common bile duct stones - Results of a nationwide survey with analysis of 8 433 common bile duct explorations in Germany</TI>
<TO>Management der Choledocholithiasis - Umfrageergebnisse und Analyse von 8 433 Gallengangsrevisionen in Deutschland, Germany</TO>
<SO>Zentralblatt fur Chirurgie</SO>
<YR>2002</YR>
<VL>127</VL>
<NO>4</NO>
<PG>282-8; discussion 288-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hyser-1999" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Hyser 1999" TYPE="JOURNAL_ARTICLE">
<AU>Hyser MJ, Chaudhry V, Byrne MP</AU>
<TI>Laparoscopic transcystic management of choledocholithiasis</TI>
<SO>American Surgeon</SO>
<YR>1999</YR>
<VL>65</VL>
<NO>7</NO>
<PG>606-9; discussion 610</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jackson-2005" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Jackson 2005" TYPE="JOURNAL_ARTICLE">
<AU>Jackson T, Treleaven D, Arlen D, D'Sa A, Lambert K, Birch DW</AU>
<TI>Management of asymptomatic cholelithiasis for patients awaiting renal transplantation</TI>
<SO>Surgical Endoscopy</SO>
<YR>2005</YR>
<VL>19</VL>
<NO>4</NO>
<PG>510-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Johansson-2003" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Johansson 2003" TYPE="JOURNAL_ARTICLE">
<AU>Johansson M, Thune A, Blomqvist A, Nelvin L, Lundell L</AU>
<TI>Management of acute cholecystitis in the laparoscopic era: results of a prospective, randomized clinical trial</TI>
<SO>Journal of Gastrointestinal Surgery</SO>
<YR>2003</YR>
<VL>7</VL>
<NO>5</NO>
<PG>642-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Johnson-2000" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Johnson 2000" TYPE="JOURNAL_ARTICLE">
<AU>Johnson SR, Koehler A, Pennington LK, Hanto DW</AU>
<TI>Long-term results of surgical repair of bile duct injuries following laparoscopic cholecystectomy</TI>
<SO>Surgery</SO>
<YR>2000</YR>
<VL>128</VL>
<NO>4</NO>
<PG>668-77</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kama-2001" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Kama 2001" TYPE="JOURNAL_ARTICLE">
<AU>Kama NA, Atli M, Doganay M, Kologlu M, Reis E, Dolapci M</AU>
<TI>Practical recommendations for the prediction and management of common bile duct stones in patients with gallstones</TI>
<SO>Surgical Endoscopy</SO>
<YR>2001</YR>
<VL>15</VL>
<NO>9</NO>
<PG>942-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Keus-2006" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Keus 2006" TYPE="COCHRANE_REVIEW">
<AU>Keus F, de Jong JAF, Gooszen HG, van Laarhoven CJHM</AU>
<TI>Laparoscopic versus open cholecystectomy for patients with symptomatic cholecystolithiasis</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2008-09-09 13:45:49 +0100" MODIFIED_BY="Sarah Louise Klingenberg">
<IDENTIFIER MODIFIED="2008-09-09 13:45:49 +0100" MODIFIED_BY="Sarah Louise Klingenberg" TYPE="DOI" VALUE="DOI: 10.1002/14651858.CD006231"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Kimura-2005" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Kimura 2005" TYPE="JOURNAL_ARTICLE">
<AU>Kimura T, Suzuki K, Umehara Y, Kawabe A, Wada H</AU>
<TI>Features and management of bile leaks after laparoscopic cholecystectomy</TI>
<SO>Journal of Hepato-Biliary-Pancreatic Surgery</SO>
<YR>2005</YR>
<VL>12</VL>
<NO>1</NO>
<PG>61-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Kjaergard-2001" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Kjaergard 2001" TYPE="JOURNAL_ARTICLE">
<AU>Kjaergard LL, Villumsen J, Gluud C</AU>
<TI>Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses</TI>
<SO>Annals of Internal Medicine</SO>
<YR>2001</YR>
<VL>135</VL>
<NO>11</NO>
<PG>982-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Krahenbuhl-2001" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Krahenbuhl 2001" TYPE="JOURNAL_ARTICLE">
<AU>Krahenbuhl L, Sclabas G, Wente MN, Schafer M, Schlumpf R, Buchler MW</AU>
<TI>Incidence, risk factors, and prevention of biliary tract injuries during laparoscopic cholecystectomy in Switzerland</TI>
<SO>World Journal of Surgery</SO>
<YR>2001</YR>
<VL>25</VL>
<NO>10</NO>
<PG>1325-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Launoy-1993" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Launoy 1993" TYPE="JOURNAL_ARTICLE">
<AU>Launoy G, Crenes-Laventure E, Dao T, Pottier D, Rougereau A, Verwaede JC, et al</AU>
<TI>[Cancer of the gallbladder. Epidemiology, diagnosis and prognostic factors]</TI>
<SO>Annales de Chirurgie</SO>
<YR>1993</YR>
<VL>47</VL>
<NO>1</NO>
<PG>18-23</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lee-2004" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Lee 2004" TYPE="JOURNAL_ARTICLE">
<AU>Lee KF, Wong J, Li JC, Lai PB</AU>
<TI>Polypoid lesions of the gallbladder</TI>
<SO>The American Journal of Surgery</SO>
<YR>2004</YR>
<VL>188</VL>
<NO>2</NO>
<PG>186-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Livingston-2004" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Livingston 2004" TYPE="JOURNAL_ARTICLE">
<AU>Livingston EH, Rege RV</AU>
<TI>A nationwide study of conversion from laparoscopic to open cholecystectomy</TI>
<SO>The American Journal of Surgery</SO>
<YR>2004</YR>
<VL>188</VL>
<NO>3</NO>
<PG>205-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lowenfels-1985" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Lowenfels 1985" TYPE="JOURNAL_ARTICLE">
<AU>Lowenfels AB, Lindstrom CG, Conway MJ, Hastings PR</AU>
<TI>Gallstones and risk of gallbladder cancer</TI>
<SO>Journal of the National Cancer Institute</SO>
<YR>1985</YR>
<VL>75</VL>
<NO>1</NO>
<PG>77-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ludwig-2002" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Ludwig 2002" TYPE="JOURNAL_ARTICLE">
<AU>Ludwig K, Lorenz D, Koeckerling F</AU>
<TI>Surgical strategies in the laparoscopic therapy of cholecystolithiasis and common duct stones</TI>
<SO>ANZ Journal of Surgery</SO>
<YR>2002</YR>
<VL>72</VL>
<NO>8</NO>
<PG>547-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Macaskill-2001" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Macaskill 2001" TYPE="JOURNAL_ARTICLE">
<AU>Macaskill P, Walter SD, Irwig L</AU>
<TI>A comparison of methods to detect publication bias in meta-analysis</TI>
<SO>Statistics in Medicine</SO>
<YR>2001</YR>
<VL>20</VL>
<NO>4</NO>
<PG>641-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mann-1994" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Mann 1994" TYPE="JOURNAL_ARTICLE">
<AU>Mann DV, Hershman MJ, Hittinger R, Glazer G</AU>
<TI>Multicentre audit of death from acute pancreatitis</TI>
<SO>The British Journal of Surgery</SO>
<YR>1994</YR>
<VL>81</VL>
<NO>6</NO>
<PG>890-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Moher-1998" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Moher 1998" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al</AU>
<TI>Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?</TI>
<SO>Lancet</SO>
<YR>1998</YR>
<VL>352</VL>
<NO>9128</NO>
<PG>609-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Newell-1992" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Newell 1992" TYPE="JOURNAL_ARTICLE">
<AU>Newell DJ</AU>
<TI>Intention-to-treat analysis: implications for quantitative and qualitative research</TI>
<SO>International Journal of Epidemiology</SO>
<YR>1992</YR>
<VL>21</VL>
<NO>5</NO>
<PG>837-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-NIH-1992" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="NIH 1992" TYPE="OTHER">
<TI>NIH consensus statement on gallstones and laparoscopic cholecystectomy. National Institutes of Health Consensus Development Conference Statement September 14-16, 1992</TI>
<SO>http://consensus.nih.gov/1992/1992GallstonesLaparoscopy090html.htm</SO>
<YR>(accessed 9 September 2008)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Okamoto-1999" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Okamoto 1999" TYPE="JOURNAL_ARTICLE">
<AU>Okamoto M, Okamoto H, Kitahara F, Kobayashi K, Karikome K, Miura K, et al</AU>
<TI>Ultrasonographic evidence of association of polyps and stones with gallbladder cancer</TI>
<SO>American Journal of Gastroenterology</SO>
<YR>1999</YR>
<VL>94</VL>
<NO>2</NO>
<PG>446-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pauletzki-1995" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Pauletzki 1995" TYPE="JOURNAL_ARTICLE">
<AU>Pauletzki J, Holl J, Sackmann M, Neubrand M, Klueppelberg U, Sauerbruch T, et al</AU>
<TI>Gallstone recurrence after direct contact dissolution with methyl tert-butyl ether</TI>
<SO>Digestive Diseases and Sciences</SO>
<YR>1995</YR>
<VL>40</VL>
<NO>8</NO>
<PG>1775-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Petroni-1995" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Petroni 1995" TYPE="JOURNAL_ARTICLE">
<AU>Petroni ML, Jazrawi RP, Grundy A, Lanzini A, Pigozzi MG, Biasio A, et al</AU>
<TI>Prospective, multicenter study on value of computerized tomography (CT) in gallstone disease in predicting response to bile acid therapy</TI>
<SO>Digestive Diseases and Sciences</SO>
<YR>1995</YR>
<VL>40</VL>
<NO>9</NO>
<PG>1956-62</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Pitluk-1979" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Pitluk 1979" TYPE="JOURNAL_ARTICLE">
<AU>Pitluk HC, Beal JM</AU>
<TI>Choledocholithiasis associated with acute cholecystitis</TI>
<SO>Archives of Surgery</SO>
<YR>1979</YR>
<VL>114</VL>
<NO>8</NO>
<PG>887-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2008" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="RevMan 2008" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2008</YR>
<PB>Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Richardson-1996" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Richardson 1996" TYPE="JOURNAL_ARTICLE">
<AU>Richardson MC, Bell G, Fullarton GM</AU>
<TI>Incidence and nature of bile duct injuries following laparoscopic cholecystectomy: an audit of 5913 cases. West of Scotland Laparoscopic Cholecystectomy Audit Group</TI>
<SO>The British Journal of Surgery</SO>
<YR>1996</YR>
<VL>83</VL>
<NO>10</NO>
<PG>1356-60</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rojas_x002d_Ortega-2003" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Rojas-Ortega 2003" TYPE="JOURNAL_ARTICLE">
<AU>Rojas-Ortega S, Arizpe-Bravo D, Marin Lopez ER, Cesin-Sanchez R, Roman GR, Gomez C</AU>
<TI>Transcystic common bile duct exploration in the management of patients with choledocholithiasis</TI>
<SO>Journal of Gastrointestinal Surgery</SO>
<YR>2003</YR>
<VL>7</VL>
<NO>4</NO>
<PG>492-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Royle-2003" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Royle 2003" TYPE="JOURNAL_ARTICLE">
<AU>Royle P, Milne R</AU>
<TI>Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches</TI>
<SO>International Journal of Technology Assessesment in Health Care</SO>
<YR>2003</YR>
<VL>19</VL>
<NO>4</NO>
<PG>591-603</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sackmann-1994" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Sackmann 1994" TYPE="JOURNAL_ARTICLE">
<AU>Sackmann M, Niller H, Klueppelberg U, von Ritter C, Pauletzki J, Holl J, et al</AU>
<TI>Gallstone recurrence after shock-wave therapy</TI>
<SO>Gastroenterology</SO>
<YR>1994</YR>
<VL>106</VL>
<NO>1</NO>
<PG>225-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sarli-2003" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Sarli 2003" TYPE="JOURNAL_ARTICLE">
<AU>Sarli L, Iusco DR, Roncoroni L</AU>
<TI>Preoperative endoscopic sphincterotomy and laparoscopic cholecystectomy for the management of cholecystocholedocholithiasis: 10-year experience</TI>
<SO>World Journal of Surgery</SO>
<YR>2003</YR>
<VL>27</VL>
<NO>2</NO>
<PG>180-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sauter-1997" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Sauter 1997" TYPE="JOURNAL_ARTICLE">
<AU>Sauter G, Kullak-Ublick GA, Schumacher R, Janssen J, Greiner L, Brand B, et al</AU>
<TI>Safety and efficacy of repeated shockwave lithotripsy of gallstones with and without adjuvant bile acid therapy</TI>
<SO>Gastroenterology</SO>
<YR>1997</YR>
<VL>112</VL>
<NO>5</NO>
<PG>1603-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schmidt-2005" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Schmidt 2005" TYPE="JOURNAL_ARTICLE">
<AU>Schmidt SC, Langrehr JM, Hintze RE, Neuhaus P</AU>
<TI>Long-term results and risk factors influencing outcome of major bile duct injuries following cholecystectomy</TI>
<SO>The British Journal of Surgery</SO>
<YR>2005</YR>
<VL>92</VL>
<NO>1</NO>
<PG>76-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Schulz-1995" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Schulz 1995" TYPE="JOURNAL_ARTICLE">
<AU>Schulz KF, Chalmers I, Hayes RJ, Altman DG</AU>
<TI>Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials</TI>
<SO>JAMA</SO>
<YR>1995</YR>
<VL>273</VL>
<NO>5</NO>
<PG>408-12</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sicklick-2005" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Sicklick 2005" TYPE="JOURNAL_ARTICLE">
<AU>Sicklick JK, Camp MS, Lillemoe KD, Melton GB, Yeo CJ, Campbell KA, et al</AU>
<TI>Surgical management of bile duct injuries sustained during laparoscopic cholecystectomy: perioperative results in 200 patients</TI>
<SO>Annals of Surgery</SO>
<YR>2005</YR>
<VL>241</VL>
<NO>5</NO>
<PG>786-92</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Stephen-2001" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Stephen 2001" TYPE="JOURNAL_ARTICLE">
<AU>Stephen AE, Berger DL</AU>
<TI>Carcinoma in the porcelain gallbladder: a relationship revisited</TI>
<SO>Surgery</SO>
<YR>2001</YR>
<VL>129</VL>
<NO>6</NO>
<PG>699-703</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sweeting-2004" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Sweeting 2004" TYPE="JOURNAL_ARTICLE">
<AU>Sweeting MJ, Sutton AJ, Lambert PC</AU>
<TI>What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data</TI>
<SO>Statistics in Medicine</SO>
<YR>2004</YR>
<VL>23</VL>
<NO>9</NO>
<PG>1351-75</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Towfigh-2001" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Towfigh 2001" TYPE="JOURNAL_ARTICLE">
<AU>Towfigh S, McFadden DW, Cortina GR, Thompson JE Jr, Tompkins RK, Chandler C, et al</AU>
<TI>Porcelain gallbladder is not associated with gallbladder carcinoma</TI>
<SO>American Surgeon</SO>
<YR>2001</YR>
<VL>67</VL>
<NO>1</NO>
<PG>7-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tuncer-2003" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Tuncer 2003" TYPE="JOURNAL_ARTICLE">
<AU>Tuncer I, Harman M, Mercan R, Ozturk M, Arslan I, Meral C, et al</AU>
<TI>The effects of ursodeoxycholic acid alone and ursodeoxycholic acid plus low-dose acetylsalicylic acid on radiolucent gallstones</TI>
<SO>Turkish Journal of Gastroenterology</SO>
<YR>2003</YR>
<VL>14</VL>
<NO>2</NO>
<PG>91-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Turcu-2000" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Turcu 2000" TYPE="JOURNAL_ARTICLE">
<AU>Turcu F</AU>
<TI>The laparoscopic approach to cholecysto-choledocholithiasis. The "rendez-vous " technique</TI>
<TO>Tehnica "rendez-vous" in abordul laparo-endoscopic al litiazei colecistocoledociene</TO>
<SO>Chirurgia</SO>
<YR>2000</YR>
<VL>95</VL>
<NO>5</NO>
<PG>463-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Venneman-2005" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Venneman 2005" TYPE="JOURNAL_ARTICLE">
<AU>Venneman NG, Renooij W, Rehfeld JF, VanBerge-Henegouwen GP, Go PM, Broeders IA, et al</AU>
<TI>Small gallstones, preserved gallbladder motility, and fast crystallization are associated with pancreatitis</TI>
<SO>Hepatology</SO>
<YR>2005</YR>
<VL>41</VL>
<NO>4</NO>
<PG>738-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Waage-2003" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Waage 2003" TYPE="JOURNAL_ARTICLE">
<AU>Waage A, Stromberg C, Leijonmarck CE, Arvidsson D</AU>
<TI>Long-term results from laparoscopic common bile duct exploration</TI>
<SO>Surgical Endoscopy</SO>
<YR>2003</YR>
<VL>17</VL>
<NO>8</NO>
<PG>1181-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wills-2002" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Wills 2002" TYPE="JOURNAL_ARTICLE">
<AU>Wills VL, Gibson K, Karihaloot C, Jorgensen JO</AU>
<TI>Complications of biliary T-tubes after choledochotomy</TI>
<SO>ANZ Journal of Surgery</SO>
<YR>2002</YR>
<VL>72</VL>
<NO>3</NO>
<PG>177-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wood-2008" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Wood 2008" TYPE="JOURNAL_ARTICLE">
<AU>Wood L, Egger M, Gluud LL, Schulz KF, Jni P, Altman GD, et al</AU>
<TI>Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study</TI>
<SO>BMJ (Clinical Research Ed.)</SO>
<YR>2008</YR>
<VL>336</VL>
<PG>601-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Yano-2003" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Yano 2003" TYPE="JOURNAL_ARTICLE">
<AU>Yano H, Kinuta M, Iwazawa T, Kanoh T, Monden T</AU>
<TI>Laparoscopic cholecystectomy for asymptomatic cholelithiasis</TI>
<SO>Digestive Endoscopy</SO>
<YR>2003</YR>
<VL>15</VL>
<NO>3</NO>
<PG>190-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Zakko-1997" MODIFIED="2008-11-12 12:03:34 +0100" MODIFIED_BY="dimitrinka nikolova" NAME="Zakko 1997" TYPE="JOURNAL_ARTICLE">
<AU>Zakko SF, Scirica JC, Guttermuth MC, Dodge J, Hajjar JJ</AU>
<TI>Ethyl propionate is more effective and less cytotoxic than methyl tert-butyl ether for topical gallstone dissolution</TI>
<SO>Gastroenterology</SO>
<YR>1997</YR>
<VL>113</VL>
<NO>1</NO>
<PG>232-7</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2008-09-09 13:56:50 +0100" MODIFIED_BY="Sarah Louise Klingenberg">
<REFERENCE ID="REF-Gurusamy-2007" MODIFIED="2008-09-09 13:56:50 +0100" MODIFIED_BY="Sarah Louise Klingenberg" NAME="Gurusamy 2007" TYPE="COCHRANE_REVIEW">
<AU>Gurusamy KS, Samraj K</AU>
<TI>Cholecystectomy versus no cholecystectomy in patients with silent gallstones</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2008-09-09 13:56:50 +0100" MODIFIED_BY="Sarah Louise Klingenberg">
<IDENTIFIER MODIFIED="2008-09-09 13:56:50 +0100" MODIFIED_BY="Sarah Louise Klingenberg" TYPE="DOI" VALUE="DOI: 10.1002/14651858.CD006230.pub2"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES>
<CHARACTERISTICS_OF_INCLUDED_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2008-05-26 16:47:32 +0100" MODIFIED_BY="Kurinchi S Gurusamy"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES"/>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2008-09-04 16:02:09 +0100" MODIFIED_BY="dimitrinka nikolova">
<APPENDIX ID="APP-01" MODIFIED="2008-09-04 16:02:09 +0100" MODIFIED_BY="dimitrinka nikolova" NO="1">
<TITLE MODIFIED="2008-09-04 16:02:09 +0100" MODIFIED_BY="dimitrinka nikolova">Search strategies</TITLE>
<APPENDIX_BODY MODIFIED="2008-09-04 15:58:09 +0100" MODIFIED_BY="dimitrinka nikolova">
<TABLE COLS="3" ROWS="6">
<TR>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Database</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Timespan</P>
</TH>
<TH ALIGN="LEFT" VALIGN="TOP">
<P>Search strategy</P>
</TH>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>The Cochrane Hepato-Biliary Group Controlled Trials Register</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>May 2008</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>(cholecystolithiasis OR cholelithiasis) AND operation*</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Issue 2, 2008</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>#1 CHOLELITHIASIS explode all trees (MeSH)<BR/>#2 (cholecystolithiasis or cholelithiasis)<BR/>#3 (#1 or #2)<BR/>#4 operation*<BR/>#5 (#3 and #4)</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>MEDLINE</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1950 to May 2008</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>("Cholelithiasis"[Mesh] OR cholecystolithiasis or cholelithiasis) AND operation* AND ((randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized [tiab] OR placebo [tiab] OR drug therapy [sh] OR randomly [tiab] OR trial [tiab] OR groups [tiab]) AND humans [mh])<BR/>
</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Embase</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1974 to May 2008</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1 CHOLELITHIASIS#.W..DE. OR cholecystolithiasis OR cholelithiasis<BR/>2 operation$<BR/>3 1 AND 2<BR/>4 RANDOM$ OR FACTORIAL$ OR CROSSOVER$ OR CROSS ADJ OVER$ OR PLACEBO$ OR DOUBL$ ADJ BLIND$ OR SINGL$ ADJ BLIND$ OR ASSIGN$ OR ALLOCAT$ OR VOLUNTEER$ OR CROSSOVER-PROCEDURE#.MJ. OR DOUBLE-BLIND-PROCEDURE#.DE. OR SINGLE-BLIND-PROCEDURE#.DE. OR RANDOMIZED-CONTROLLED-TRIAL#.DE.<BR/>5 3 AND 4</P>
</TD>
</TR>
<TR>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>Science Citation Index Expanded</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>1945 to May 2008</P>
</TD>
<TD ALIGN="LEFT" VALIGN="TOP">
<P>#1 TS=(cholecystolithiasis or cholelithiasis)<BR/>#2 TS=(operation*)<BR/>#3 #1 AND #2<BR/>#4 TS=(random* or placebo* or blind* or meta-analysis)<BR/>#5 #3 AND #4</P>
</TD>
</TR>
</TABLE>
<P/>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>